文献速递消化道肿瘤与早癌食管胃疾病与幽门螺杆菌

GPR30阳性胃主细胞在化生中经PDK依赖的细胞竞争被清除而非去分化

GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia.
PubMed 文献 · Gastroenterology · 2020-02-04

该研究通过转录组分析鉴定GPR30为小鼠胃主细胞特异性标志物,并建立Gpr30-rtTA谱系追踪模型。结果显示化生刺激后主细胞经GPR30和PDK依赖的细胞竞争被清除,而非去分化参与化生;敲除GPR30或抑制PDK可保留主细胞并减弱颈谱系扩增。

要点

  • GPR30是小鼠胃主细胞的特异性标志物,不标记干细胞。
  • 化生刺激下主细胞经GPR30/PDK依赖的细胞竞争被清除。
  • 敲除GPR30或抑制PDK可保留主细胞并减弱颈谱系扩增。

核心结论

  • 多数主细胞在化生过程中丢失,不太可能通过去分化贡献于胃癌发生。
  • SPEM细胞扩增源于颈祖细胞的代偿反应而非主细胞去分化。

研究设计与样本

  • 对Mist1-CreERT追踪细胞(伴或不伴主细胞清除)进行转录组分析。
  • 构建Gpr30-rtTA与TetO-Cre;R26-TdTomato小鼠进行谱系追踪。
  • 使用Mist1-CreERT、Kitl-CreERT、Tff1-Cre和Tff2-Cre小鼠交叉报告小鼠进行额外追踪。
  • 使用高剂量他莫昔芬、DMP-777或幽门螺杆菌感染诱导胃化生。
  • 使用TetO-KrasG12D、LSL-KrasG12D和LSL-HrasG12V小鼠表达突变Ras。

主要发现

  • GPR30在胃上皮主细胞中特异性表达,在峡部干细胞中无表达且无腺体谱系追踪。
  • 在GPR30+主细胞中表达突变Kras未导致化生或异型增生,而是标记主细胞数量减少和颈谱系代偿性扩增。
  • 高剂量他莫昔芬、DMP-777或幽门螺杆菌均减少标记的主细胞数量。
  • 化生刺激后主细胞经GPR30和PDK依赖的细胞竞争被清除。
  • 敲除GPR30或抑制PDK活性可保留主细胞数量并减弱颈谱系细胞扩增。

临床怎么用

  • 提示胃化生中主细胞丢失而非去分化,临床关注颈祖细胞代偿机制。
  • GPR30和PDK通路可能作为干预胃化生的潜在靶点,但需进一步验证。

局限性

  • 研究仅基于小鼠模型,结果外推至人类需谨慎。
  • 原文未明确报告样本量、P值等统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Gastric chief cells, a mature cell type that secretes digestive enzymes, have been proposed to be the origin of metaplasia and cancer through dedifferentiation or transdifferentiation. However, studies supporting this claim have had technical limitations, including issues with the specificity of chief cell markers and the toxicity of drugs used. We therefore sought to identify genes expressed specifically in chief cells and establish a model to trace these cells. METHODS: We performed transcriptome analysis of Mist1-CreERT-traced cells, with or without chief cell depletion. Gpr30-rtTA mice were generated and crossed to TetO-Cre mice, and lineage tracing was performed after crosses to R26-TdTomato mice. Additional lineage tracing experiments were performed using Mist1-CreERT, Kitl-CreERT, Tff1-Cre, and Tff2-Cre mice crossed to reporter mice. Mice were given high-dose tamoxifen or DMP-777 or were infected with Helicobacter pylori to induce gastric metaplasia. We studied mice that expressed mutant forms of Ras in gastric cells, using TetO-KrasG12D, LSL-KrasG12D, and LSL-HrasG12V mice. We analyzed stomach tissues from GPR30-knockout mice. Mice were given dichloroacetate to inhibit pyruvate dehydrogenase kinase (PDK)-dependent cell competition. RESULTS: We identified GPR30, the G-protein-coupled form of the estrogen receptor, as a cell-specific marker of chief cells in gastric epithelium of mice. Gpr30-rtTA mice crossed to TetO-Cre;R26-TdTomato mice had specific expression of GPR30 in chief cells, with no expression noted in isthmus stem cells or lineage tracing of glands. Expression of mutant Kras in GPR30+ chief cells did not lead to the development of metaplasia or dysplasia but, instead, led to a reduction in labeled numbers of chief cells and a compensatory expansion of neck lineage, which was derived from upper Kitl+ clones. Administration of high-dose tamoxifen, DMP-777, or H pylori decreased the number of labeled chief cells. Chief cells were eliminated from epithelia via GPR30- and PDK-dependent cell competition after metaplastic stimuli, whereas loss of GRP30 or inhibition of PDK activity preserved chief cell numbers and attenuated neck lineage cell expansion. CONCLUSIONS: In tracing studies of mice, we found that most chief cells are lost during metaplasia and therefore are unlikely to contribute to gastric carcinogenesis. Expansion of cells that coexpress neck and chief lineage markers, known as spasmolytic polypeptide-expressing metaplasia, does not occur via dedifferentiation from chief cells but, rather, through a compensatory response from neck progenitors to replace the eliminated chief cells.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Hata M, Kinoshita H, Hayakawa Y, et al. GPR30-Expressing Gastric Chief Cells Do Not Dedifferentiate But Are Eliminated via PDK-Dependent Cell Competition During Development of Metaplasia. Gastroenterology. 2020. PMID: 32032583. doi:10.1053/j.gastro.2020.01.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。